About Divergence
Divergence is a company based in Saint Louis (United States) founded in 1999 was acquired by Monsanto in February 2011. Divergence has raised $11.8 million across 12 funding rounds from investors including United States Department of Agriculture, Monsanto and HHS. Divergence operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Saint Louis, United States
- SectorsHealthcare
- Website divergence.com
- Social LinkedIn
- Acquired by Monsanto (Feb 2011)
- Total Equity Funding$11.8M (USD)
in 12 rounds
- Latest Funding Round$150K (USD), Grant
Jan 2010
- Investors
- Acquired byMonsanto
(Feb 2011)
Funding Insights of Divergence
Divergence has successfully raised a total of $11.8M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $150 thousand completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.8M
- Total Rounds 12
- Last Round Grant — $150,000
- First Round $100,000
(Feb 2008)
- Investors Count 6
Latest 10 of 12 funding rounds of Divergence with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2010 | $150,000 | Grant | – | – | |
| Nov 2009 | $150,000 | Grant | – | – | |
| Sep 2009 | $350,000 | Grant | – | – | |
| Apr 2009 | $1.2M | Grant | – | – | |
| Mar 2009 | $500,000 | Grant | – | – | |
| Mar 2009 | $500,000 | Grant | – | – | |
| Feb 2009 | $11.8M | Series C | – | Prolog Ventures, Arab Gulf Programme for Development | – |
| Jun 2008 | $108,576 | Grant | – | – | |
| May 2008 | $80,000 | Grant | – | – | |
| Apr 2008 | $80,000 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Divergence
Divergence has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Monsanto and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-focused venture capital investments are made in US sectors. | – | prologventures.com | Newark, United States | |
- | – | cultiviansbx.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Provides microcredit services tailored to the agriculture industry. | 1980 | agfund.org | Riyadh, Saudi Arabia | |
Leadership is provided on agriculture, food, and rural development matters. | 1862 | usda.gov | - | |
Genetically modified seeds and biotechnology traits are developed for farmers. | 1901 | monsanto.com | St. Louis, United States |
Investor details for Divergence
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Divergence
1 people are tracked at Divergence (1 in leadership).
| Name | Role | Group |
|---|---|---|
Derek Rapp | Chief Executive Officer | Leadership |
Complete people profiles for Divergence
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Divergence
4 dated milestones of Divergence across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Divergence is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Grant, of $150K.
- Exit Acquired by Monsanto.
Competitors of Divergence
Divergence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Divergence
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Divergence
Websites that share an audience with Divergence (divergence.com).
Websites whose visitors overlap most with Divergence. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bibcorporation.com | 100% | – | – | View details | |
soilfirst.com | soilfirst.com | 100% | – | – | – |
nature-technologies.com | nature-technologies.com | 100% | – | – | – |
greenmethods.com | greenmethods.com | 100% | – | #3,322,072 | – |
wmmg.com | wmmg.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Divergence
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Divergence
Complete news archive for Divergence
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Divergence
10 companies that operate in the same segment as Divergence (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Divergence
Divergence was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Divergence is headquartered in Saint Louis, United States. It is registered at Saint Louis, Missouri, United States.
Divergence is a funded company, having raised a total of $11.8M across 12 funding rounds to date. The company's 1st funding round was a Grant of $80K, raised on Feb 2008.
Divergence was founded in 1999 in Saint Louis, United States, and operates in the genomics and informatics sectors focused on agriculture and infectious diseases. Parasitic nematodes are targeted through discovery and development of resistant crops and safer agrochemicals. Platform technologies such as RNAi, Harvest, and STEM are provided for broader pest management applications.
Divergence's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Divergence has 7 investors. Key investors include United States Department of Agriculture, Monsanto, HHS, National Science Foundation, and Prolog Ventures.
Yes. Divergence was acquired by Monsanto in February 2011.